Celebrating ‘The Twilight Saga: New Moon’

In honor of the opening day of New Moon, the latest film in The Twilight Saga, we thought we ...

The Cheryl Behind the Cheryl

Known to many as the long-suffering (ex)wife of funnyman Larry David, the man behind Seinfeld, ...

BlogTalkRadio Host of the Week: Alfred McComber from...

By Christina Blodgett In our continuing effort to spotlight more members of the BlogTalkRadio ...

 

Your show will start playing after this message

Profile

Jim Johnston

http://www.castlemans.org


Country: United States

Language: English

Visit on Facebook

On Demand Episodes

Links

Listeners

  • India DC
  • Jim Johnston
  • Dr. Arnold Oppenheim
  • jingnic
  • AmandaMckellevy
  • Jack Marino

Friends

  • Jack Bouffard
  • Stupid Cancer Show

Comments

There are no comments at this time.

Castleman's Disease Discussion  

Jim Johnston is the International Castleman's Disease Organization Executive Director. The International Castleman's Disease Organization (ICDO) is a patient advocacy forum designed for individuals who have been diagnosed with this rare disorder. Castleman's Disease (CD) is initially characterized by a benign single or multiple growths within the lymphatic tissue. It is normally found by scans in the neck, chest, abdomen or pelvis. This support group is intended to provide an interactive discussion for patients, families, and caregivers of Castleman's Disease. Information provided is for general education purposes only and should not be construed as medical advice nor is is this information intended to replace the advice of your physician. This forum will also serve as a platform to present and discuss pending, current, and proposed clinical trials for Castleman's.

  • On Demand Episodes

    Original Air Date:

    An Interview with Jerry Zeldis, MD, PhD (pre-recorded)

    Dr Zeldis is CEO of Celgene Global Health and Chief Medical Officer of Celgene Corporation, Summit, NJ. Prior to that he was Celgene’s Senior Vice President of Clinical Research and Medical Affairs. Dr. Zeldis attended Brown University for an A.B., M.S., followed by Yale University for an M.Phil, M.D., Ph.D. in Molecular Biophysics and Biochemmistry (immunochemistry. Dr Zeldis trained in Internal Medicine at the UCLA Center for the Health Sciences and Gastroenterology at the Massachusetts General Hospital and Harvard School of Medicine. He was Assistant Professor of Medicine at University of California, Davis, Clinical Associate Professor of Medicine at Cornell Medical School and Professor of Clinical Medicine at the Robert Wood Johnson Medical School in New Brunswick, New Jersey. Dr. Zeldis is currently on the International Castlemans Disease Organization (ICDO) and was past ICDO Medical Director.

    No Comments

  • Original Air Date:

    Dr. Guido J.K.Tricot, MD, PhD, Professor, Department of Medicine; Salt Lake City, UT

    Dr Tricot is the “Professor, Department of Medicine; Director, Utah Blood and Marrow Transplant and Myeloma Program," Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. This interview will encompass the capability of Huntsman Cancer Institute to provide Castlemans Disease patients with a diagnosis and treatment plan for this rare disease. In addition to capabilities and treatment, Dr. Tricot will discuss clinical trials available at Huntsman and an overview of the relation between Multiple Myeloma and Castleman’s Disease. A specific definition of what is Castleman's, the risk factors involved and other related diseases to a Castleman’s will be reviewed.

    No Comments

  • Original Air Date:

    Frits VanRhee, MD, PhD., Professor of Medicine, UAMS Little Rock, AR

    This presentation is an International Castlemans Disease Organization interview with Dr Frits Van Rhee, Professor of Medicine and Director of Clinical Research for the Myeloma Institute for Research and Therapy University of Arkansas for Medical Sciences, Little Rock, AR. Dr Van Rhee will be discussing the research, diagnosis and treatment of Castlemans Disease at the University of Arkansas for Medical Sciences. Under the direction of Dr Bart Barlogie, Professor of Medicine and Pathology and Director, Myeloma the Institute UAMS is one of the premiere facilities treating Castlemans Disease world-wide.

    No Comments

  • Original Air Date:

    Mr Doug Mancino, ICDO General Counsel

    Mr. Mancino is the International Castlemans Disease (ICDO) General Counsel representing the legal medical affairs of the organization. Mr. Mancino's interview will discuss the responsibility of the patient, patient advocate, and caregiver of a patient with Castlemans Disease. Specifically, physician / patient confidentiality, release of medical information and the Health Insurance Portability and Accountability Act (HIPAA). Mr. Mancino represents major non-Profit organization in California where charity fund raising events are sponsored to support cancer research efforts. Mr. Mancino was a part of “ThinkCure”, a charity that will raise funds for cancer research at the City of Hope and Children’s Hospital in Los Angeles. “They’re promoting ThinkCure as the official charity of the LA Dodgers.” “ They’re very interested in finding a cure,” Mr. Mancino said.

    No Comments

  • Original Air Date:

    Dr. Kenneth Anderson and Dr. Nikhil Munshi Interview

    Dr. Kenneth Anderson is the Craft Family Professor of Medicine at Harvard Medical School and Chief, Division of Hematologic Neoplasia, Dana Farber Cancer Institute. Dr Anderson is also the ICDO Chief Medical Officer and Scientific Advisory Board, chair. Dr. Nikhil Munshi is an Associate Professor of Medicine, Dana Farber Cancer Institute. An open discussion with Dr Anderson and Dr Munshi will include an overview of the Dana Farber Cancer Institute, specific affiliation to Castlemans Disease, DFC treatment plans and therapies. Dr. Anderson and Dr. Munshi will discuss the Dana Farber Cancer Institute’s contribution to the research and treatment of Castlemans Disease at the DFCI / Harvard Medical School.

    Comments (1)

  • Original Air Date:

    Castleman's Disease Premiere

    Castleman's Disease (CD) is a rare disease categorized as non-Hodgkin. The International Castleman's Disease Organization (ICDO) is a patient advocacy network created to provide patient information on this rare disease, introduce CD “centers of excellence”, and refer patients to clinicians responsible for treating a diagnosis of Castleman’s Disease. This premiere International Castleman’s Disease show will introduce a new health program series to BlogTalkRadio (BTR) that will openly discuss issues related to patient advocacy. Our broadcast will reach patients of the International Castleman’s Disease Organization in the U.S. and abroad. An aggressive CD BTR schedule is planned that will present academic medical facilities involved with treating CD patients and introductions from each of the ICDO Board of Directors.

    Comments (1)

  • < Previous Episodes

Everything Else

Listen

 

 Participate

 

 Services and Terms

 

 Corporate

 

 BlogTalkRadio

 
BlogTalkRadio is a provider of thousands of internet talk radio shows. Our streaming and archived shows are produced by anyone that wants to be an internet radio host.
Give it a listen  and  
© 2009 BlogTalkRadio.com. All Rights Reserved.